TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
邵幼雲SHAO, YU-YUN
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
83筆
41
Hung-Yang Kuo, Zhong-Zhe Lin, Raymond Kuo, Wen-Yi Shau, Chiu-Lin Lai, Yen-Yun Yang, Yu-Yun Shao, Chiun Hsu, Wen-Fan Cheng, Ann-Lii Cheng, James Chih-Hsin Yang, and Mei-Shu Lai. The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia. Oncologist 2015 Sep; 20: 1051-1057#
42
Yu-Yun Shao, Chih-Hung Hsu, Kun-Huei Yeh, Ho-Min Chen, Yi-Chun Yeh, Chiu-Lin Lai, Zhong-Zhe Lin, Ann-Lii Cheng, Mei-Shu Lai. Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan. Clin Colorectal Cancer 2015 Sep; 14: 177-184#
43
Tzu-Hsuan Lin*, Yu-Yun Shao*, Soa-Yu Chan, Chung-Yi Huang, Chih-Hung Hsu, and Ann-Lii Cheng. High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib. Clin Cancer Research 2015 Aug; 21: 3678-3684 (*co-first authors)#
44
Chao-Chi Yeh, Chih-Hung Hsu, Yu-Yun Shao, Wen-Ching Ho, Mong-Hsun Tsai, Wen-Chi Feng, Lu-Ping Chow. Integrated SILAC and iTRAQ quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer. Mol Cell Proteomics 2015 Jun; 14: 1527-1545#
45
Yu-Yun Shao, Wen-Yi Shau, Soa-Yu Chan, Li-Chun Lu, Chih-Hung Hsu, Ann-Lii Cheng. Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials. Oncology 2015 May; 88: 345-352#
46
Bin-Chi Liao*, Yu-Yun Shao*, Ho-Min Chen, Wen-Yi Shau, Zhong-Zhe Lin, Raymond Nienchen Kuo, Chiu-Ling Lai, Kuo-Hsing Chen, Ann-Lii Cheng, James Chih-Hsin Yang, Mei-Shu Lai. Comparative Effectiveness of First-line Platinum-based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma. Clin Lung Cancer 2015 Mar; 16: 137-143 (*co-first authors)#
47
Kuo-Hsing Chen, Yu-Yun Shao, Zhong-Zhe Lin, Yi-Chun Yeh, Wen-Yi Shau, Raymond Nienchen Kuo, Ho-Min Chen, Chiu-Ling Lai, Kun-Huei Yeh, Ann-Lii Cheng, Mei-Shu Lai. Type 2 Diabetes Mellitus Is Associated With Increased Mortality in Chinese Asian Patients Receiving Curative Surgery for Colon Cancer. The Oncologist 2014 Sep; 19:951-958#
48
Yu-Yun Shao, Ming-Chih Ho, Ann-Lii Cheng, Chih-Hung Hsu. Long-Term Disease-Free Survival Achieved by Anti-angiogenic Therapy plus Surgery in a Hepatocellular Carcinoma Patient with Extensive Liver Involvement and Lung Metastases. Journal of the Formosan Medical Association 2014 Aug; 113: 577-578#
49
Li-Chun Lu, Yu-Yun Shao, Yi-Hsuan Lee, Min-Shu Hsieh, Chi-Huang Hsiao, Hsiao-Hui Lin, Hsiang-Fong Kao, Yu-Yi Ma, Feng-Chu Yen, Ann-Lii Cheng, Chih-Hung Hsu. β-catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma. Oncology 2014 Jul; 87:159-166#
50
Chih-Hung Hsu, Ying-Chun Shen, Yu-Yun Shao, Chiun Hsu, Ann-Lii Cheng. Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives. Journal of Hepatocellular Carcinoma 2014 Jun; 1: 85-99.
